In the case of RT combination with a checkpoint blockade (CTLA-4) and checkpoint stimulation (OX40), Young et al. showed that administration of anti-CTLA-4 prior to RT, followed by OX40 stimulation, was the optimal combination in a mouse model of colorectal cancer [43]. Here, TNFRSF4 is linked to colorectal cancer.